These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16981800)
1. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800 [TBL] [Abstract][Full Text] [Related]
2. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population. Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370 [TBL] [Abstract][Full Text] [Related]
3. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. Prescott JD; Factor S; Pill M; Levi GW J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836 [TBL] [Abstract][Full Text] [Related]
4. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. Shetty S; Secnik K; Oglesby AK J Manag Care Pharm; 2005 Sep; 11(7):559-64. PubMed ID: 16137213 [TBL] [Abstract][Full Text] [Related]
5. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. Margolis J; Barron JJ; Grochulski WD J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416 [TBL] [Abstract][Full Text] [Related]
6. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119 [TBL] [Abstract][Full Text] [Related]
7. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217 [TBL] [Abstract][Full Text] [Related]
8. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894 [TBL] [Abstract][Full Text] [Related]
9. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population. Bergeson JG; Worley K; Louder A; Ward M; Graham J J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475 [TBL] [Abstract][Full Text] [Related]
10. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pelletier EM; Shim B; Ben-Joseph R; Caro JJ Pharmacoeconomics; 2009; 27(6):479-90. PubMed ID: 19640011 [TBL] [Abstract][Full Text] [Related]
11. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO. Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603 [TBL] [Abstract][Full Text] [Related]
12. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643 [TBL] [Abstract][Full Text] [Related]
13. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. Asche CV; Singer ME; Jhaveri M; Chung H; Miller A J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256 [TBL] [Abstract][Full Text] [Related]
14. Disease-related and all-cause health care costs of elderly patients with gout. Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118 [TBL] [Abstract][Full Text] [Related]
15. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods. Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613 [TBL] [Abstract][Full Text] [Related]
16. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. Tencer T; Friedman HS; Li-McLeod J; Johnson K J Manag Care Pharm; 2007; 13(9):790-8. PubMed ID: 18062730 [TBL] [Abstract][Full Text] [Related]
17. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271 [TBL] [Abstract][Full Text] [Related]
18. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population. Buono JL; Mathur K; Averitt AJ; Andrae DA J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443 [TBL] [Abstract][Full Text] [Related]
19. Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control. Karkare S; Fridman M; Dang-Tan T; Lu J; Smolarz BG; DeKoven M; Iyer NN J Manag Care Spec Pharm; 2019 Jun; 25(6):658-668. PubMed ID: 30730232 [TBL] [Abstract][Full Text] [Related]
20. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. Cooke CE; Fatodu H J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]